Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Obesity, sleep, smoking, and inactivity show the strongest links to hypertension in U.S. adults

2

Apr 2026

Obesity, sleep, smoking, and inactivity show the strongest links to hypertension in U.S. adults

A cross-sectional analysis of 20,912 U.S. adults found that obesity, overweight, inadequate physical activity, smoking, and short or long sleep were each associated with higher odds of hypertension, while overall diet quality by HEI-2015 was not significantly associated. Sleep associations differed by sex, and lower sodium intake remained linked to lower odds of hypertension in sensitivity analyses.

Northumbria University spinout earns CE mark for breath sampling device

2

Apr 2026

Northumbria University spinout earns CE mark for breath sampling device

A medical device company spun out of Northumbria University has reached a significant milestone — receiving CE marking for a breath sampling platform that peer-reviewed research has demonstrated can reliably collect saliva-free exhaled breath condensates (EBC) from the deep lung, making it the first technology of its type to achieve this distinction.

New dual drugs eliminate tumors when combined with immunotherapy

2

Apr 2026

New dual drugs eliminate tumors when combined with immunotherapy

Researchers at Johns Hopkins University and the University of Maryland School of Pharmacy have developed a set of novel, first-in-class drugs that inhibit hypoxia-inducible factors 1 and 2, a pair of transcription factors considered to be "master regulators" of cancer progression.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.